Turning Point Therapeutics skyrockets after Bristol Myers buyout offer Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Turning Point Therapeutics (TPTX) up 115% after announcing a definitive merger agreement under which Bristol Myers Squibb (BMY) will acquire the company for $76.00 per share
- Chegg (CHGG) up 5% after authorizing the increase of its securities repurchase program up to an aggregate of $2B of Chegg's common stock and/or convertible notes
- Kohl's (KSS) up 4% after The Wall Street Journal reported the company has received takeover bids from Sycamore Partners and retail holding company Franchise Group (FRG)
UP AFTER EARNINGS -
- StoneCo (STNE) up 11%
- Okta (OKTA) up 14%
- Quanex (NX) up 5%
- Lululemon (LULU) up 1%
DOWN AFTER EARNINGS -
- Joann (JOAN) down 17%
- Zumiez (ZUMZ) down 8%
- Crowdstrike (CRWD) down 4%
- RH (RH) down 3%
LOWER -
- Tesla (TSLA) down 5% after Reuters reported CEO Elon Musk said the company needs to cut staff by around 10%, noting he had a "super bad feeling" about the economy
- Micron (MU) down 4% after Piper Sandler analyst Harsh Kumar downgraded shares to Underweight from Neutral with a price target of $70, down from $90
Symbols:
TPTXTurning Point Therapeutics
CHGG NX JOAN ZUMZ CRWD - $173.90 /
+12.29 (+7.60%)
RH - $301.87 /
+11.87 (+4.09%)
TSLA - $775.00 /
+34.16 (+4.61%)
MU KSS STNE OKTA BMY LULU - $302.67 /
+12.77 (+4.40%)
Keywords: Fly Intel, Wall Street, Top Stories, Stocks